United States: A New World Health Organization- commissioned study published research showed that mobile phone usage does not cause an elevated risk of brain cancer.
More about the study
With the great expansion of wireless technology utilization, the frequency of brain cancers has not increased correspondingly, found the study.
The case also applies to those who make long phone calls or those who have experienced mobile phones for more than ten years, Reuters reported.
The authors gathered 63 papers/reports looking at the effects of transmission assessments made between 1994 and 2022 and evaluated by eleven investigators from then different countries, including the Australian government’s radiation protection agency.
The work evaluated the impacts of radiofrequency, which is incorporated into mobile phones and TV, baby alarms, and radar, said Mark Elwood, the co-author, and professor of cancer epidemiology at the University of Auckland, New Zealand.
He said, “None of the major questions studied showed increased risks,” as Reuters reported.
About the results of the study
The review concerned cancers of the brain in adults and children, cancer of the pituitary salivary glands, and leukaemia, as well as risks associated with mobile phone use, base stations or transmitters, or occupation exposure. Other types of cancer will be presented elsewhere.
The review was accomplished in the same manner as the previous reviews of similar work. The WHO and other international health bodies said before that there is no scientific proof of the health dangers of using radiation from mobile phones, but added that more research needs to be done on this.
However, currently, it belongs to “Group 2B, possible carcinogens” by IARC, which is used when the organization didn’t find any connection between the substance and cancer but did not rule out this possibility.
The agency’s advisory group has said that the classification needs to be reassessed as soon as possible due to new data, and based on the results obtained, the classification was made in 2011.
As for WHO, its evaluations will be released in the Q1 of next year.